A healthcare technology-focused venture capital firm invests primarily in pre-Seed, Seed, Bridge, and Series A financing rounds and is currently investing from their second fund. Typical investment size ranges from $100-250k, with potential for follow on. The firm welcomes global opportunities, but will invest primarily in the “Americas” (North or South America).
The firm is particularly interested in the areas of mental health, longevity, and chronic conditions, and technologies that can promote prevention, better access, and better quality of care. With their current fund, the firm seeks to invest into more biotech companies, and will consider all modalities. The firm will also continue to invest in medical devices, diagnostics, and digital health companies that address their key focus areas, with an open interest in various types of technologies within these main sectors. In terms of stage of development, the firm is open to pre-clinical, pre-revenue generating companies with demonstrated proof of concept.
The firm does not have specific company or management team requirements. The firm can act as either a lead or co-investor, will typically seek board representation when leading.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment